Ascentage Pharma’s Bcl-2 inhibitor APG-2575 granted orphan drug Designation by FDA to treat chronic lymphocytic leukaemia

The US FDA’s Centre for Drug Evaluation and Research, (Credit: The U.S. Food and Drug Administration/Wikipedia.org)